期刊文献+

神经外科夫西地酸应用情况及合理性分析 被引量:7

Status and Rationality of Utilization of Fusidic Acid in Neurosurgical Patients
下载PDF
导出
摘要 目的:考察神经外科夫西地酸(FA)使用情况和合理用药分析。方法:随机抽取住院病房病案,采用Excel数据处理进行统计的方法对我院近3年来神经外科住院病历进行调查,分析FA的应用情况及不合理因素。结果:随机抽取FA病历150例,有效病历136例,围术期预防性用药132例,Ⅰ类切口116例,使用不合理主要表现在预防应用未按《抗菌药物临床应用指导原则》执行,用法用量错误,给药方案,合并用药等方面。结论:我院神经外科FA应用存在不合理现象,应加强对临床合理用药培训和相关指导原则的学习。 OBJECTIVE:To investigate the status and rationality of using fusidic acid(FA) in neurosurgical patients.METHODS:By a random sampling of the inpatients,the medical records in the neurosurgical department in recent 3 years were reviewed to analyze the status and rationality of the utilization of FA by using Excel data processing.RESULTS:A total of 150 FA medical records were randomly selected,of which,136 were valid,132 had perioperative preventive use of antibiotics,and 116 had type I incisions.The irrationality in the use of antibiotics manifested as failure to follow guiding principle for clinical use of the antibiotics in the preventive medication,errors in administration and dosage,dosage regimens and combined drug use etc.CONCLUSION:The use of FA in neurosurgical patients is somewhat irrational,thus it is necessary to tighten training on clinical rational use of drugs and learning on relative guiding principles in clinic.
出处 《中国医院用药评价与分析》 2011年第3期227-229,共3页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 夫西地酸 神经外科 合理用药 预防用药 Fluidic acid Neurosurgery Rational use of drug Preventive medication
  • 相关文献

参考文献10

二级参考文献69

  • 1陈莉延,梁标.夫西地酸治疗社区获得性革兰阳性球菌性肺炎[J].广东医学,2006,27(2):275-276. 被引量:3
  • 2张永信.抗菌药物新品种临床评价[J].世界临床药物,2006,27(9):532-536. 被引量:2
  • 3朱红燕,唐志刚.夫西地酸的抗菌药理与临床应用[J].交通医学,2007,21(2):211-212. 被引量:18
  • 4戚佳叶,王林.耐甲氧西林葡萄球菌耐药形势和治疗药物[J].中国高等医学教育,2007(7):94-95. 被引量:1
  • 5Jennifer M. BSAC standardized disc susceptibility testing method[J]. J Antimicrob Chemother, 2001, 48, Suppl SI, 43-57.
  • 6Nishijima S, Kurokawa I, Nakaya H. Susceptibility change to antibiotics of Staphylococcus aureus strains isolated from skin infections between July 1994 and November 2000[J]. J Infect Chemother, 2002, 8(2): 187-189.
  • 7Denis O, Nonhoff C, Byl B, et al. Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital:microbiological and clinical features[J]. J Antimicrob Chemother, 2002, 50(3): 383-391.
  • 8Pittet D, Wenzel RP. Nosocomial bloodstream infection. Secular trends in rates, mortality, and contribution to total hospital deaths. [J]. Arch Intern Med,1995, 155:1177
  • 9Turndge J. Fusidic acid pharmacology, pharmacokinetics and pharmacodynamics. [J]. Int J Antimicrob Agents, 1999, 12: S23
  • 10Budavari S. The Merck Index. 11th ed. [M]. Rahway, New Jersey: Merck and Company, 1989: 676

共引文献82

同被引文献69

引证文献7

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部